OMCL Omnicell, Inc.

NASDAQ
$37.30

Omnicell, Inc. (OMCL) is expected to report earnings on October 29, 2026, before the market open. The consensus earnings estimate is $0.25 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +5.0% since its last earnings release on July 30, 2026.

Omnicell Beat Expectations, Raises Earnings Guidance
Thursday, July 30, 2026 · 6:30 AM ET
Earnings Date
3rd Quarter, Sep 2026
Oct 29
Thursday · 6:30 AM ET
Earnings Whisper
-
vs $0.25 (GAAP)
Rev est $312.99M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $36.96

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Omnicell, Inc.

Omnicell, Inc., provides automation & business information solutions to update medication administration process & manage costly medical supplies for operational efficiency & patient safety. Its operating business segments are acute care & non-acute care.

Sector

Healthcare

Industry

Medical Instruments/Supply